Viscosupplementation with hyaluronic acid in the treatment for cartilage lesions: A review of current evidence and future directions

被引：20

作者：

Clegg T.E. ^{[1
]}

Caborn D. ^{[1
]}

Mauffrey C. ^{[1
,2
]}

机构：

[1] Department of Orthopaedic Surgery, University of Louisville, Louisville, KY

[2] Orthopedic Traumatology, Denver Health Medical Centre, Denver, CO 80204

来源：

European Journal of Orthopaedic Surgery & Traumatology | 2013年 / 23卷 / 2期

关键词：

Hyaluronic acid; Treatment of cartilage lesions; Viscosupplementation;

D O I：

10.1007/s00590-012-0940-0

中图分类号：

学科分类号：

摘要：

Diseases involving the articular cartilage are one of the leading causes of physical impairment among the adult population. While surgical technique and advancement have allowed us effective means at treating these diseases, this is not without significant risk and morbidity. With a very solid safety profile, viscosupplementation with hyaluronic acid (HA) derivatives has become an excellent modality for treating diseased articular cartilage. Recent literature supports the use of HA not only in the management of the pain associated with osteoarthritis but also as a disease-modifying agent as well. Further studies have started to define exciting new roles for viscosupplementation in the treatment for acute injuries to the joint microenvironment. © 2012 Springer-Verlag.

引用

页码：119 / 124

页数：5

共 29 条

[1]

Ayral X., Injections in the treatment of osteoarthritis, Best Prac Res Clin Rheumatol, 15, pp. 609-626, (2001)

[2]

Tehranzadeh J., Booya F., Root J., Cartilage metabolism in osteoarthritis and the influence of viscosupplementation and steroid: A review, Acta Radiol, 3, pp. 288-296, (2005)

[3]

Lo G., Michael L., McAlindon T., Intra-articular hyaluronic acid in treatment of knee osteoarthritis: A meta-analysis, JAMA, 290, 23, pp. 3115-3121, (2003)

[4]

Watterson J.R., Esdaile J.M., Viscosupplementation: Therapeutic mechanisms and clinical potential in osteoarthritis of the knee, J Am Acad Orthop Surg., 8, 5, pp. 277-284, (2000)

[5]

Moreland L.W., Intra-articular hyaluronan (hyaluronic acid) and hylans for the treatment of osteoarthritis: Mechanisms of action, Arthritis Res Ther, 5, 2, pp. 54-67, (2003)

[6]

Buckwalter J.A., Saltzman C., Brown T., The impact of osteoarthritis: Implications for research, Clin Orthop Relat Res, 427, SUPPL., (2004)

[7]

Physicians Desk Reference, (2007)

[8]

Goldberg V.M., Buckwalter J.A., Hyaluronans in the treatment of osteoarthritis of the knee: Evidence for disease-modifying activity, Osteoarth Cartil, 13, 3, pp. 216-224, (2005)

[9]

Chevalier X., Jerosch J., Goupille P., Van Dijk N., Luyten F.P., Scott D.L., Bailleul F., Pavelka K., Single, intra-articular treatment with 6 ml hylan G-F 20 in patients with symptomatic primary osteoarthritis of the knee: A randomised, multicentre, double-blind, placebo controlled trial, Ann Rheum Dis, 69, 1, pp. 113-119, (2010)

[10]

Conrozier T., Jerosch J., Beks P., Kemper F., Euller-Ziegler L., Bailleul F., Chevalier X., Prospective, multi-centre, randomised evaluation of the safety and efficacy of five dosing regimens of viscosupplementation with hylan G-F 20 in patients with symptomatic tibio-femoral osteoarthritis: A pilot study, Arch Orthop Trauma Surg, 129, 3, pp. 417-423, (2009)

← 1 2 3 →